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Background
Self-report of nonmedical prescription opioid use (NMPU)
is a cornerstone of drug abuse surveillance, policymaking,
and treatment service planning, but misclassification cre-
ates bias and may confuse or undermine NMPU estimates
[1]. We detected old OxyContin (OC) abuse reports long
after a reformulated version (OP) was released (August
2010). This study explored sources of possible NMPU
misclassification and proposed solutions.
Materials and methods
A mixed-methods approach identified demographic, beha-
vioral, and cognitive factors influencing endorsement of
old formulations in: a) multivariable regression analyses of
NMPU data from the ASI-MV surveillance program [2]
examined predictors of endorsing old (vs. new) formula-
tions during the post-reformulation period (n = 8032); b)
prevalence estimates of OC availability from an online
recreational drug user forum survey (fall 2013; n = 459);
and c) semistructured interviews (n = 29) and cognitive
interviews (n = 7) among residential and outpatient sub-
stance abuse treatment program clients reporting past
2-year use of OC/OP. A coding guide identified patterns
and themes of misidentification in transcribed interviews.
Results
From December 2010 to January 2014, 57 percent of
ASI-MV respondents reporting any OC/OP indicated
OC use. In multivariable analyses, OC reporting was
greater among Black users (p < 0.05) who were not pri-
marily opioid abusers (p < 0.10), and increased over
time among people using opioids as prescribed (p <
0.01). Early post-reformulation, OC use was endorsed by
users aged 21–34 and people having recently initiated
heroin, but trends reversed over time (p < 0.05). Online
forum users reporting NMPU also reported obtaining
OC during fall 2013 (18.5%). Qualitative analyses indi-
cated that source of drug identification knowledge, trust
and relationship with their drug source, context in
which the drug was obtained, and motivations for
NMPU contributed to misidentification of OC/OP and
other products. “Counterfeits” were noted as a common
element of the illicit market and may partially explain
endorsement rates, especially early post-reformulation,
when street prices for the old formulation (and counter-
feits) were high. Cognitive factors such as lacking images
(front, back, dosage) and labels, confusion between gen-
erics and branded products, and literacy level suggest
item-level modifications.
Conclusions
Possible misclassification of OC/OP and other prescription
opioids may be as high as 20 percent among NMPUs and
is higher among younger users and limited NMPU experi-
ence. Findings have implications for surveillance, policy
evaluations, and research using self-reported NMPU.
Suggestions include presenting: 1) pill images within a
compound in a single view, 2) key milligram increments,
3) street terminology, 4) pill images to scale, both sides,
correct coloring, and markings.
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